ELOVL1-IN-1 is a potent and selective inhibitor of the ELOVL1 enzyme, effectively reducing the synthesis of very long-chain fatty acids (VLCFAs). It serves as a valuable research tool for studying adrenoleukodystrophy (ALD) pathogenesis and has demonstrated utility in both in vitro and in vivo experimental models of this disease.